Press Releases

Soni's via Adobe Stock

16

Aug

SAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressure

Pretoria, 16 August 2026 – The South African Health Products Regulatory Authorit...

Share

nikolettamuhari via Adobe Stock

08

Jul

Health regulators warn against the use or dispensing of recalled Semaglutide and Tirzepatide

Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Profe...

Share

23

May

SAHPRA and the SAPC Crack Down on Unlawful Manufacturing of Unregistered GLP-1/ GIP Medicines

Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (...

Share

RESOLUTE: Dr. Boitumelo Semete – Makokotlela, CEO of SAHPRA, addressing the media in Pretoria.

24

Mar

SAHPRA Recalls Affected batches of Citro-Soda Regular Following Safety Concerns

Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority...

Share

SnerdCo via Adobe Stock

20

Mar

SAHPRA to brief media on the recall of specified batches of Citro-Soda Regular amid safety concerns

Pretoria, 20 March 2026 – The South African Health Products Regulatory Authority...

Share

SnerdCo via Adobe Stock

23

Feb

SAHPRA Responds to Carte Blanche Report on Alleged GMP Non-compliance at Adcock Ingram Clayville Facility

Pretoria, 23 February 2026 – The South African Health Products Regulatory Author...

Share

Adobe Stock

13

Feb

SAHPRA Fast-Tracks Access to Critical Foot and Mouth Disease Vaccines to Protect South Africa’s Livestock

Pretoria, 13 February 2026 –The South African Health Products Regulatory A...

Share

Kanchanit via Adobe Stock

08

Jan

Warning: Selenium and zinc picolinate-containing products for children

For immediate release Pretoria, 8 January 2026 – The South African Health ...

Share

Olga Gorkun via Adobe Stock

01

Dec

SAHPRA Accepted as a Member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)

Embargo: Immediate release Pretoria, 1 December 2025 – The South African Health ...

Share

Olga Gorkun via Adobe Stock

19

Nov

South Africa, PATH, and Wellcome launch world’s first AI framework for mental health at G20 Social Summit

[Embargoed] Johannesburg, 19 November 2025 – As artificial intelligence (AI) inc...

Share

Olga Gorkun via Adobe Stock

12

Nov

SAHPRA warns the public about GLP-1 products sold through social media platforms

Pretoria, 11 November 2025 – The South African Health Products Regulatory Author...

Share

Julian via Adobe Stock

27

Oct

SAHPRA Registers Lenacapavir

Pretoria, 27 October 2025 – The South African Health Products Regulatory Authori...

Share

jhenning via Pixabay

28

Sep

SAHPRA clarifies that paracetamol is safe to use in pregnancy, at recommended doses

Pretoria, 28 September 2025 – The South African Health Products Regulatory Autho...

Share

chokniti via Adobe Stock

27

Aug

SAHPRA Approves Mpox Test Using AMRH Continental EUL Procedure

Pretoria, 27 August 2025 –The South African Health Products Regulatory Authority...

Share

chokniti via Adobe Stock

15

Jul

SAHPRA‘s position on anti-cancer medications in South Africa

Pretoria, 15 July 2025 – The South African Health Products Regulatory Authority ...

Share

chokniti via Adobe Stock

11

Jun

SAHPRA alerts the public about fake licence holders

Pretoria, 11 June 2025—The South African Health Products Regulatory Authority (S...

Share

@Pixabay

22

May

SAHPRA Approves First WHO EUL Mpox Test Kit

Pretoria, 22 May 2025 –The South African Health Product...

Share

@Adobe Stock - photo by LuuqasDesign

04

Apr

SAHPRA joins the Medical Device Single Audit Programme

Pretoria, 04 April 2025 –The South African Health Products Regulatory Authority ...

Share

@Pexels - photo by Pavel Danilyuk

17

Jan

SAHPRA clarifies the benefits and risks of medroxyprogesterone acetate

Pretoria, 17 January 2025 – The South African Health Products Regulatory Authori...

Share

@Pexels

29

Nov

SAHPRA Offices will be unavailable on 29 November 2024

Please note that SAHPRA Head Office, including Cape Town and Durban Regional Off...

Share

Press Releases

SAHPRA recalls certain batches of Enalapril 10mg Arya Commonly used to treat high blood pressure

Health regulators warn against the use or dispensing of recalled Semaglutide and Tirzepatide

SAHPRA and the SAPC Crack Down on Unlawful Manufacturing of Unregistered GLP-1/ GIP Medicines

SAHPRA Recalls Affected batches of Citro-Soda Regular Following Safety Concerns

SAHPRA to brief media on the recall of specified batches of Citro-Soda Regular amid safety concerns

SAHPRA Responds to Carte Blanche Report on Alleged GMP Non-compliance at Adcock Ingram Clayville Facility

SAHPRA Fast-Tracks Access to Critical Foot and Mouth Disease Vaccines to Protect South Africa’s Livestock

Warning: Selenium and zinc picolinate-containing products for children

SAHPRA Accepted as a Member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)

South Africa, PATH, and Wellcome launch world’s first AI framework for mental health at G20 Social Summit

SAHPRA warns the public about GLP-1 products sold through social media platforms

SAHPRA Registers Lenacapavir

SAHPRA clarifies that paracetamol is safe to use in pregnancy, at recommended doses

SAHPRA Approves Mpox Test Using AMRH Continental EUL Procedure

SAHPRA‘s position on anti-cancer medications in South Africa

SAHPRA alerts the public about fake licence holders

SAHPRA Approves First WHO EUL Mpox Test Kit

SAHPRA joins the Medical Device Single Audit Programme

SAHPRA clarifies the benefits and risks of medroxyprogesterone acetate

SAHPRA Offices will be unavailable on 29 November 2024

Contact us

Quick Menu

I want to..

Subscribe